ID   CDK8_HUMAN              Reviewed;         464 AA.
AC   P49336; Q5VUF3; Q6ISB5;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   05-OCT-2010, entry version 95.
DE   RecName: Full=Cell division protein kinase 8;
DE            EC=2.7.11.22;
DE            EC=2.7.11.23;
DE   AltName: Full=Cyclin-dependent kinase 8;
DE   AltName: Full=Mediator complex subunit CDK8;
DE   AltName: Full=Mediator of RNA polymerase II transcription subunit CDK8;
DE   AltName: Full=Protein kinase K35;
GN   Name=CDK8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   MEDLINE=96004640; PubMed=7568034; DOI=10.1073/pnas.92.19.8871;
RA   Tassan J.-P., Jaquenoud M., Leopold P., Schultz S.J., Nigg E.A.;
RT   "Identification of human cyclin-dependent kinase 8, a putative protein
RT   kinase partner for cyclin C.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8871-8875(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   MEDIATOR COMPLEX.
RX   MEDLINE=98403427; PubMed=9734358; DOI=10.1016/S1097-2765(00)80131-8;
RA   Sun X., Zhang Y., Cho H., Rickert P., Lees E., Lane W.S., Reinberg D.;
RT   "NAT, a human complex containing Srb polypeptides that functions as a
RT   negative regulator of activated transcription.";
RL   Mol. Cell 2:213-222(1998).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SMCC
RP   COMPLEX.
RX   MEDLINE=99149022; PubMed=10024883; DOI=10.1016/S1097-2765(00)80178-1;
RA   Gu W., Malik S., Ito M., Yuan C.-X., Fondell J.D., Zhang X.,
RA   Martinez E., Qin J., Roeder R.G.;
RT   "A novel human SRB/MED-containing cofactor complex, SMCC, involved in
RT   transcription regulation.";
RL   Mol. Cell 3:97-108(1999).
RN   [7]
RP   ERRATUM.
RA   Gu W., Malik S., Ito M., Yuan C.-X., Fondell J.D., Zhang X.,
RA   Martinez E., Qin J., Roeder R.G.;
RL   Mol. Cell 3:541-541(1999).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-173.
RX   MEDLINE=20445178; PubMed=10993082; DOI=10.1038/35024111;
RA   Akoulitchev S., Chuikov S., Reinberg D.;
RT   "TFIIH is negatively regulated by cdk8-containing mediator
RT   complexes.";
RL   Nature 407:102-106(2000).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH MAML1.
RX   PubMed=15546612; DOI=10.1016/j.molcel.2004.10.014;
RA   Fryer C.J., White J.B., Jones K.A.;
RT   "Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and
RT   coordinate activation with turnover.";
RL   Mol. Cell 16:509-520(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   MEDIATOR COMPLEX.
RX   PubMed=15175163; DOI=10.1016/j.molcel.2004.05.006;
RA   Sato S., Tomomori-Sato C., Parmely T.J., Florens L., Zybailov B.,
RA   Swanson S.K., Banks C.A.S., Jin J., Cai Y., Washburn M.P.,
RA   Conaway J.W., Conaway R.C.;
RT   "A set of consensus mammalian mediator subunits identified by
RT   multidimensional protein identification technology.";
RL   Mol. Cell 14:685-691(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE MEDIATOR
RP   COMPLEX, AND ASSOCIATION OF THE MEDIATOR COMPLEX WITH RNA POLYMERASE
RP   II.
RX   PubMed=15989967; DOI=10.1016/j.molcel.2005.05.015;
RA   Zhang X., Krutchinsky A., Fukuda A., Chen W., Yamamura S., Chait B.T.,
RA   Roeder R.G.;
RT   "MED1/TRAP220 exists predominantly in a TRAP/Mediator subpopulation
RT   enriched in RNA polymerase II and is required for ER-mediated
RT   transcription.";
RL   Mol. Cell 19:89-100(2005).
RN   [12]
RP   INTERACTION WITH CTNNB1; GLI3; MED1; MED6; MED12 AND MED23.
RX   PubMed=17000779; DOI=10.1128/MCB.00443-06;
RA   Zhou H., Kim S., Ishii S., Boyer T.G.;
RT   "Mediator modulates Gli3-dependent Sonic hedgehog signaling.";
RL   Mol. Cell. Biol. 26:8667-8682(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-410 AND SER-413, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-189 AND CYS-424.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of the Mediator complex, a coactivator
CC       involved in regulated gene transcription of nearly all RNA
CC       polymerase II-dependent genes. Mediator functions as a bridge to
CC       convey information from gene-specific regulatory proteins to the
CC       basal RNA polymerase II transcription machinery. Mediator is
CC       recruited to promoters by direct interactions with regulatory
CC       proteins and serves as a scaffold for the assembly of a functional
CC       preinitiation complex with RNA polymerase II and the general
CC       transcription factors. Phosphorylates the CTD (C-terminal domain)
CC       of the large subunit of RNA polymerase II (RNAp II), which may
CC       inhibit the formation of a transcription initiation complex.
CC       Phosphorylates CCNH leading to down-regulation of the TFIIH
CC       complex and transcriptional repression. Recruited through
CC       interaction with MAML1 to hyperphosphorylate the intracellular
CC       domain of NOTCH, leading to its degradation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- CATALYTIC ACTIVITY: ATP + [DNA-directed RNA polymerase] = ADP +
CC       [DNA-directed RNA polymerase] phosphate.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- SUBUNIT: Component of the Mediator complex, which is composed of
CC       MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13,
CC       MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21,
CC       MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31,
CC       CCNC, CDK8 and CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8
CC       subunits form a distinct module termed the CDK8 module. Mediator
CC       containing the CDK8 module is less active than Mediator lacking
CC       this module in supporting transcriptional activation. Individual
CC       preparations of the Mediator complex lacking one or more distinct
CC       subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and
CC       TRAP. The cylin/CDK pair formed by CCNC/CDK8 also associates with
CC       the large subunit of RNA polymerase II. Interacts with CTNNB1,
CC       GLI3 and MAML1.
CC   -!- INTERACTION:
CC       P24863:CCNC; NbExp=2; IntAct=EBI-394377, EBI-395261;
CC       Q15797:SMAD1; NbExp=1; IntAct=EBI-394377, EBI-1567153;
CC   -!- SUBCELLULAR LOCATION: Nucleus (Probable).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49336-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49336-2; Sequence=VSP_029970;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X85753; CAA59754.1; -; mRNA.
DR   EMBL; AL590108; CAH72300.1; -; Genomic_DNA.
DR   EMBL; AL159159; CAH72300.1; JOINED; Genomic_DNA.
DR   EMBL; AL159159; CAI16960.1; -; Genomic_DNA.
DR   EMBL; AL590108; CAI16960.1; JOINED; Genomic_DNA.
DR   EMBL; CH471075; EAX08386.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08387.1; -; Genomic_DNA.
DR   EMBL; BC069634; AAH69634.1; -; mRNA.
DR   EMBL; BC104492; AAI04493.1; -; mRNA.
DR   EMBL; BC105950; AAI05951.1; -; mRNA.
DR   EMBL; BC107601; AAI07602.1; -; mRNA.
DR   IPI; IPI00026791; -.
DR   IPI; IPI00879595; -.
DR   PIR; I37227; I37227.
DR   RefSeq; NP_001251.1; -.
DR   UniGene; Hs.382306; -.
DR   ProteinModelPortal; P49336; -.
DR   SMR; P49336; 22-343.
DR   DIP; DIP-32595N; -.
DR   IntAct; P49336; 18.
DR   MINT; MINT-3017285; -.
DR   STRING; P49336; -.
DR   PhosphoSite; P49336; -.
DR   PRIDE; P49336; -.
DR   Ensembl; ENST00000381527; ENSP00000370938; ENSG00000132964.
DR   GeneID; 1024; -.
DR   KEGG; hsa:1024; -.
DR   UCSC; uc001uqr.1; human.
DR   UCSC; uc001uqs.1; human.
DR   CTD; 1024; -.
DR   GeneCards; GC13P026828; -.
DR   H-InvDB; HIX0037326; -.
DR   HGNC; HGNC:1779; CDK8.
DR   MIM; 603184; gene.
DR   PharmGKB; PA26315; -.
DR   eggNOG; prNOG05645; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P49336; -.
DR   OMA; GQPQMGQ; -.
DR   OrthoDB; EOG91G5PZ; -.
DR   PhylomeDB; P49336; -.
DR   BRENDA; 2.7.11.22; 247.
DR   BRENDA; 2.7.11.23; 247.
DR   Reactome; REACT_71; Gene Expression.
DR   NextBio; 4301; -.
DR   ArrayExpress; P49336; -.
DR   Bgee; P49336; -.
DR   CleanEx; HS_CDK8; -.
DR   Genevestigator; P49336; -.
DR   GermOnline; ENSG00000132964; Homo sapiens.
DR   GO; GO:0016592; C:mediator complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; IEA:EC.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0008353; F:RNA polymerase II carboxy-terminal domain k...; IEA:EC.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0045449; P:regulation of transcription; IEA:UniProtKB-KW.
DR   GO; GO:0006350; P:transcription; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Repressor; Serine/threonine-protein kinase; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN         1    464       Cell division protein kinase 8.
FT                                /FTId=PRO_0000085797.
FT   DOMAIN       21    335       Protein kinase.
FT   NP_BIND      27     35       ATP (By similarity).
FT   COMPBIAS    373    377       Poly-Gln.
FT   ACT_SITE    151    151       Proton acceptor (By similarity).
FT   BINDING      52     52       ATP (By similarity).
FT   MOD_RES     410    410       Phosphothreonine.
FT   MOD_RES     413    413       Phosphoserine.
FT   VAR_SEQ     370    370       Missing (in isoform 2).
FT                                /FTId=VSP_029970.
FT   VARIANT     189    189       D -> N (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041980.
FT   VARIANT     424    424       R -> C (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041981.
FT   MUTAGEN     173    173       D->A: Abrogates kinase activity and
FT                                TFIIH-dependent transcriptional
FT                                repression.
SQ   SEQUENCE   464 AA;  53284 MW;  00CBAB6CE354605F CRC64;
     MDYDFKVKLS SERERVEDLF EYEGCKVGRG TYGHVYKAKR KDGKDDKDYA LKQIEGTGIS
     MSACREIALL RELKHPNVIS LQKVFLSHAD RKVWLLFDYA EHDLWHIIKF HRASKANKKP
     VQLPRGMVKS LLYQILDGIH YLHANWVLHR DLKPANILVM GEGPERGRVK IADMGFARLF
     NSPLKPLADL DPVVVTFWYR APELLLGARH YTKAIDIWAI GCIFAELLTS EPIFHCRQED
     IKTSNPYHHD QLDRIFNVMG FPADKDWEDI KKMPEHSTLM KDFRRNTYTN CSLIKYMEKH
     KVKPDSKAFH LLQKLLTMDP IKRITSEQAM QDPYFLEDPL PTSDVFAGCQ IPYPKREFLT
     EEEPDDKGDK KNQQQQQGNN HTNGTGHPGN QDSSHTQGPP LKKVRVVPPT TTSGGLIMTS
     DYQRSNPHAA YPNPGPSTSQ PQSSMGYSAT SQQPPQYSHQ THRY
//
